Humacyte, Inc. (HUMA) Insider Ownership

Historic Insider Ownership Trends

As of April 25, 2026, Humacyte's top three insider holders are Llc Ayabudge (TenPercentOwner, 8.19Mn shares), Brady W Dougan (Director, 1.15Mn shares), Brady W Dougan (Director, 510.16K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Llc Ayabudge - 8,191,140 0 21 Aug, 2023
Brady W Dougan - 0 1,148,240 27 Aug, 2021
Laura E Niklason President, Ceo And Director 0 510,161 16 Dec, 2021
Brady W Dougan - 510,161 0 16 Dec, 2021
Shamik J Parikh Chief Medical Officer 318,600 0 17 Nov, 2025
Dale A. Sander Cfo And Chief Corp. Deve. Off. 313,100 0 17 Nov, 2025
Laura E Niklason President, Ceo And Director 243,851 0 21 Nov, 2024
Brady W Dougan - 0 243,851 21 Nov, 2024
Gordon M Binder - 160,000 50,000 15 May, 2024
Kathleen Sebelius - 91,207 0 08 Apr, 2025
Max N. Wallace - 56,550 0 21 Nov, 2023
William Edward Tente Chief Regulatory Officer 52,519 0 27 Aug, 2021
Dale A. Sander Cfo And Chief Corp. Deve. Off. 0 40,600 14 Apr, 2025
Michael T. Constantino - 32,950 0 08 Apr, 2025
William John Scheessele Chief Commercial Officer 22,018 0 15 Apr, 2025
Charles Bruce Green - 8,400 0 08 Apr, 2025
Max N. Wallace - 0 8,005 21 May, 2024
Jeffrey Harold Lawson Chief Surgical Officer 7,877 0 27 Aug, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
16 Nov, 2025 Shamik J Parikh Common Stock A 311,100 $0.00 318,600 D A
16 Nov, 2025 Dale A. Sander Common Stock A 311,100 $0.00 313,100 D A
16 Nov, 2025 Brady W Dougan Stock Options (right to buy) A 311,100 $0.00 311,100 I A
16 Nov, 2025 Laura E Niklason Stock Options (right to buy) A 311,100 $0.00 311,100 D A
18 Aug, 2025 Brady W Dougan Common Stock D 549,360 $1.83 1,691,685 I S
18 Aug, 2025 Laura E Niklason Common Stock D 549,360 $1.83 1,691,685 I S
19 Aug, 2025 Brady W Dougan Common Stock D 1,100,000 $1.63 591,685 I S
19 Aug, 2025 Laura E Niklason Common Stock D 1,100,000 $1.63 591,685 I S
20 Aug, 2025 Laura E Niklason Common Stock D 591,685 $1.58 0 I S
20 Aug, 2025 Brady W Dougan Common Stock D 591,685 $1.58 0 I S
12 Jun, 2025 Emery N. Brown Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Michael T. Constantino Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Keith Anthony Jones Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Charles Bruce Green Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Kathleen Sebelius Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 John Philip Bamforth Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Diane Seimetz Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Todd Pope Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Susan Richards Windham-Bannister Stock Options (right to buy) A 80,000 $0.00 80,000 D A
12 Jun, 2025 Max N. Wallace Stock Options (right to buy) A 80,000 $0.00 80,000 D A